Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Acceptability of Less Harmful Alternatives to Cigarettes
- Status
- COMPLETED
- Phase
- NA
Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With Gemcitabine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
- Status
- COMPLETED
- Phase
- PHASE4
Parenteral Nutrition Support for Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pancreatic Adenocarcinoma Gene Environment Risk Study
- Status
- RECRUITING
- Phase
- N/A
Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy
- Status
- UNKNOWN
- Phase
- NA
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Fatigue and Pancreas and Bile Duct Cancer Study
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA